| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,938 |
FY2025 Third Quarter Earnings Release
|
9 May 2025 8:26AM |
$50.680 |
$44.820 |
fallen by
11.56%
|
|
NWS - Price-sensitive ASX Announcement
Full Release
Key Points
- News Corporation reported FY2025 Third Quarter Earnings for the period ended March 31, 2024.
- Consolidated revenues showed year-over-year growth, driven primarily by strong results in Digital Real Estate Services and Dow Jones.
- Adjusted EBITDA increased compared to the prior-year quarter, reflecting continued operational improvements.
- Digital Real Estate Services segment saw robust revenue and earnings growth, fueled by strong digital listings and higher consumer engagement.
- Dow Jones delivered solid results, with increased digital subscriptions and strong performance in professional information business.
- Book Publishing segment experienced lower revenues due to fewer frontlist title releases and ongoing market challenges.
- Subscription Video Services faced revenue pressures from a changing industry landscape and subscriber declines.
- News Media segment revenues remained stable, with digital advertising and subscription revenues partially offsetting declines in print.
- The company continued to reduce costs and drive efficiencies across all segments.
- News Corporation emphasized strategic initiatives focused on digital transformation, margin improvement, and shareholder returns.
- Management commentary expressed cautious optimism for the remainder of the fiscal year, citing macroeconomic challenges and a focus on profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$5,201 |
FUM as at 30 April 2025
|
9 May 2025 8:26AM |
$2.160 |
$1.760 |
fallen by
18.52%
|
|
GQG - Price-sensitive ASX Announcement
Full Release
Key Points
- GQG Partners Inc. announced FUM as at 30 April 2025.
- FUM reached A$151.6 billion.
- The FUM figure reflects an increase from previous reporting periods.
- Breakdown provided by investment strategy and currency base.
- Growth observed across global and emerging markets equity strategies.
- Commitment to transparency with monthly FUM reporting.
- No other major company updates or operational changes disclosed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coronado Global Resources Inc (CRN) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$553 |
As Filed SEC Form 10-Q Q1 2025
|
9 May 2025 8:26AM |
$0.170 |
$0.330 |
risen by
94.12%
|
|
CRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Coronado Global Resources Inc. filed its Q1 2025 SEC Form 10-Q for the period ended March 31, 2024.
- The report covers financial results, including revenues, costs, profits, and production volumes.
- Market conditions impacting coal prices and demand are discussed, emphasizing metallurgical coal.
- Operational challenges, such as adverse weather and geological events, are noted.
- Liquidity position, capital resources, and expenditure plans are outlined.
- Legal proceedings, contingent liabilities, and risk factors are disclosed.
- The company addresses its sustainability, safety, and environmental initiatives.
- Analysis includes management’s discussion and analysis, as well as financial statements.
- Risk management strategies and controls and procedures are described.
- Potential impacts of market volatility, regulatory changes, and commodity price risks are discussed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Laramide Resources Ltd (LAM) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$179 |
Notification regarding unquoted securities - LAM
|
9 May 2025 8:26AM |
$0.755 |
$0.630 |
fallen by
16.56%
|
|
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$163 |
Financial Results for Quarter Ending 31 March 2025
|
9 May 2025 8:25AM |
$2.990 |
$1.070 |
fallen by
64.21%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Product revenue increased significantly year-over-year, mainly due to higher adoption of RECELL in the U.S.
- Clinical development advanced with ongoing trials in soft tissue reconstruction and vitiligo.
- Gross profit improved, reflecting favorable product mix and operational efficiencies.
- Operating expenses rose as a result of investments in sales, marketing, and research activities.
- Net loss was reported, but the company emphasized a strong cash position to support future operations.
- Key milestones were achieved in regulatory submissions and clinical programs.
- Strategic initiatives focused on expanding addressable markets and driving adoption.
- Positive outlook for continued revenue growth through expanded indications and market reach.
- Management reiterated commitment to innovation and improving patient outcomes.
- Financial guidance and strategic priorities for the upcoming quarters were provided.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$163 |
AVITA Medical Q1 2025 Earnings Presentation
|
9 May 2025 8:25AM |
$2.990 |
$1.070 |
fallen by
64.21%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Q1 2025 earnings presentation delivered on May 9, 2024
- Continued expansion of RECELL device in U.S. burn and soft tissue repair markets
- Transitioned to a direct sales model in Canada to drive commercial performance
- Achieved key regulatory milestones, including FDA approvals and product label expansions
- Advanced multiple pipeline projects, such as RECELL GO and new indications
- Strengthened operational efficiency and reduced operating expenses year-over-year
- Reported increased quarterly revenues and improved gross margin
- Maintained strong cash position to support business initiatives
- Reiterated fiscal year 2025 financial guidance and growth expectations
- Strategic focus on market expansion, innovation, and operational excellence
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$163 |
AVITA Medical Reports Q1 2025 Financial Results
|
9 May 2025 8:25AM |
$2.990 |
$1.070 |
fallen by
64.21%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- AVITA Medical, Inc. reported its Q1 2025 financial results, showing continued revenue growth.
- The company’s RECELL product line drove increased adoption in wound care and burn treatment segments.
- Operational highlights included commercial expansion and new product development initiatives.
- AVITA Medical provided updates on regulatory approvals and ongoing clinical trials.
- The company continues to focus on strategic market expansion and strengthening its financial position.
- Management emphasized commitment to innovation and long-term growth opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sims Limited (SGM) ORDINARY FULLY PAID |
Materials |
$3,517 |
Application for quotation of securities - SGM
|
9 May 2025 8:25AM |
$15.270 |
$18.200 |
risen by
19.19%
|
|
| Genmin Limited (GEN) ORDINARY FULLY PAID |
Materials |
$28 |
Non-executive Chair provides A$2.0 million in funding
|
9 May 2025 8:25AM |
$0.027 |
$0.008 |
fallen by
70.37%
|
|
GEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Genmin Limited received A$2.0 million funding from Non-executive Chair Mr. Kerry Stokes AC.
- The funding is structured as an unsecured loan with a 12-month maturity period.
- Interest on the loan is set at 8% per annum, payable quarterly in arrears.
- The funds will be used to support Genmin's working capital and ongoing operations.
- The transaction was on arm's length terms and not considered a related party transaction under ASX rules.
- The funding demonstrates continued board support as Genmin advances its African iron ore projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Winchester Energy Limited (WEL) ORDINARY FULLY PAID |
Energy |
$3 |
Winchester successfully defends legal proceedings
|
9 May 2025 8:25AM |
$0.001 |
$0.002 |
risen by
100%
|
|
WEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Winchester Energy Limited has successfully defended legal proceedings.
- The court ruled in favor of Winchester, dismissing all claims.
- No adverse findings or damages were imposed on the company.
- No costs were awarded to the plaintiff.
- The outcome removes legal uncertainty for Winchester Energy Limited.
- The company assures shareholders of its strong legal position.
- Winchester will now focus on ongoing business operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Piedmont Lithium Limited (PLL) ORDINARY FULLY PAID |
Materials |
- |
Earnings Presentation Q1 2025
|
9 May 2025 8:25AM |
$0.100 |
$0.140 |
risen by
40%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$3,721 |
Ceasing to be a substantial holder
|
9 May 2025 8:24AM |
$1.745 |
$2.900 |
risen by
66.19%
|
|
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$642 |
Ceasing to be a substantial holder
|
9 May 2025 8:24AM |
$11.270 |
$12.780 |
risen by
13.40%
|
|
| 8Common Ltd (8CO) ORDINARY FULLY PAID |
Information Technology |
$7 |
Change of Director's Interest Notice - N Lim
|
9 May 2025 8:24AM |
$0.015 |
$0.031 |
risen by
106.67%
|
|
| Doctor Care Anywhere Group PLC (DOC) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$44 |
Change of Director's Interest Notice - John Stier
|
9 May 2025 8:24AM |
$0.084 |
$0.120 |
risen by
42.86%
|
|
| Mineral Resources Limited (MIN) ORDINARY FULLY PAID |
Materials |
$11,048 |
Ceasing to be a substantial holder
|
9 May 2025 8:24AM |
$20.740 |
$55.900 |
risen by
169.53%
|
|
| Tempest Minerals Limited (TEM) ORDINARY FULLY PAID |
Materials |
$8 |
Change to Managing Director Remuneration Arrangements
|
9 May 2025 8:24AM |
$0.004 |
$0.007 |
risen by
75%
|
|
| Athena Resources Limited (AHN) ORDINARY FULLY PAID |
Materials |
$14 |
Completion of RC Drilling at Byro South
|
9 May 2025 8:24AM |
$0.004 |
$0.006 |
risen by
50%
|
|
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$275 |
Top 20 Option Holders
|
9 May 2025 8:23AM |
$0.053 |
$0.160 |
risen by
201.89%
|
|
| REA Group Ltd (REA) ORDINARY FULLY PAID |
Communication Services |
$24,339 |
REA Group Q3 FY25 financial information released
|
9 May 2025 8:22AM |
$250.080 |
$184.220 |
fallen by
26.34%
|
|
REA - Price-sensitive ASX Announcement
Full Release
Key Points
- REA Group reported revenue and EBITDA growth for Q3 FY25.
- Australian residential business benefited from increased listing volumes and higher depth penetration.
- Commercial and developer segments also contributed positively to overall revenue.
- International businesses, including India and Southeast Asia, showed ongoing momentum and growth.
- Ongoing investments in technology and data capabilities to drive innovation.
- Disciplined cost management supported margin expansion.
- Strategic initiatives include expanding product offerings and strengthening data assets.
- Continued focus on customer experience improvements.
- Positive outlook expressed for the remainder of FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$275 |
Distribution Schedule
|
9 May 2025 8:22AM |
$0.053 |
$0.160 |
risen by
201.89%
|
|
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$275 |
Application for quotation of securities - EUR
|
9 May 2025 8:22AM |
$0.053 |
$0.160 |
risen by
201.89%
|
|
| Civmec Limited (CVL) ORDINARY FULLY PAID |
Industrials |
$731 |
Investor Presentation - Q3 FY25
|
9 May 2025 8:20AM |
$0.905 |
$1.435 |
risen by
58.56%
|
|
CVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Q3 FY25 saw continued revenue growth and increased margins for Civmec Limited.
- Order book remains robust with significant new contract awards and extensions in resources, energy, and infrastructure.
- Operational highlights include successful project delivery, expansion of fabrication and construction capacity, and strong safety performance.
- The company maintains a diversified project pipeline, reducing reliance on the resources sector alone.
- Sustainability initiatives advanced, with a focus on environmental responsibility and community engagement.
- Financial position remains strong, supporting ongoing investment in capacity and capability.
- Civmec remains committed to operational excellence, safety, and delivering value to shareholders.
- The outlook is positive, supported by a healthy pipeline and favourable market conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Civmec Limited (CVL) ORDINARY FULLY PAID |
Industrials |
$731 |
Civmec Business Update - Q3 FY25
|
9 May 2025 8:20AM |
$0.905 |
$1.435 |
risen by
58.56%
|
|
CVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Civmec reported strong revenue and profitability growth for Q3 FY25.
- The company maintained a robust order book and secured new contracts across multiple sectors.
- Ongoing project execution contributed to improved operational performance.
- Safety, workforce development, and training remain key priorities.
- Civmec continued to invest in facilities and equipment to support business expansion.
- Operational efficiency and client relationship management were emphasized.
- The company’s financial position remains strong, with a positive future outlook.
- Civmec is actively pursuing new opportunities in the resources, energy, infrastructure, and defence sectors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Air New Zealand Limited (AIZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$1,649 |
Notice of share buyback
|
9 May 2025 8:20AM |
$0.560 |
$0.510 |
fallen by
8.93%
|
|
Call 1300 880 160
Start a chat
Schedule a call
